Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy.

The use of genes as therapeutic drugs will likely involve non-viral delivery systems. While traditionally less effective for gene expression, the advantages of a non-viral delivery system include ease of production, lower toxicity, and no risk of infection. However, most non-viral systems do not incorporate a mechanism for gene transport into the nucleus. Nuclear localization signal peptides can combine the increased expression of viral delivery systems with the safety and ease of preparation of non-viral delivery systems. A novel non-viral delivery vehicle consisting of a conglomerate of a synthetic nuclear localization signal peptide derived from the SV40 virus, a luciferase encoding PGL3 plasmid, and a cationic lipid DOTAP:DOPE (1:1 w/w) liposome was transfected into SKnSH mammalian neuroblastoma cells. A three-fold increase in luciferase expression was seen with the delivery system containing a NLS peptide over cationic liposome controls. Examination of the factors that limit the rate of transgene expression can potentially lead to the discovery of new ways to improve the efficiency and efficacy of nonviral methods of gene therapy.

[1]  P. Silver,et al.  Analysis of conserved binding proteins for nuclear localization sequences. , 1993, Journal of cell science.

[2]  D. Goldfarb,et al.  Most nuclear proteins are imported by a single pathway. , 1993, Experimental cell research.

[3]  P. Godowski,et al.  Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach. , 1996, Journal of pharmaceutical sciences.

[4]  R. Ghirlando,et al.  Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. , 1993, Biochemistry.

[5]  M. Goldberg,et al.  Structural and functional organization of the nuclear envelope. , 1995, Current opinion in cell biology.

[6]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[7]  F. Szoka,et al.  Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. , 1996, Biochemistry.

[8]  X. Leng,et al.  Genetically defined nuclear localization signal sequence of bovine papillomavirus E1 protein is necessary and sufficient for the nuclear localization of E1-beta-galactosidase fusion proteins. , 1994, The Journal of general virology.

[9]  P. D. Cook,et al.  Lipid membrane permeability of 2'-modified derivatives of phosphorothioate oligonucleotides. , 1994, Journal of pharmaceutical sciences.

[10]  M. Geschwind,et al.  Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Transfer of the NGF gene into cells by a HSV-1 vector. , 1994, Brain research. Molecular brain research.

[11]  P. Hayes,et al.  Gene therapy for cystic fibrosis in humans by liposome-mediated DNA transfer: the production of resources and the regulatory process. , 1994, Gene therapy.

[12]  A. Brasier,et al.  Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. , 1989, BioTechniques.

[13]  M. G. Pappas.  The Biotechnology of Gene Therapy , 1996 .

[14]  N. Allbritton,et al.  Source of nuclear calcium signals. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Herweijer,et al.  Gene transfer into mammalian cells using histone-condensed plasmid DNA. , 1996, Human gene therapy.